1 Min Read
Jan 2 (Reuters) - Sanofi :
* Sanofi and its vaccines global business unit Sanofi Pasteur confirmed today the end of their vaccine joint-venture with MSD (known as Merck & Co. Inc., in the United States and Canada), Sanofi Pasteur MSD (SPMSD).
* Sanofi SA and Merck & Co Inc had previously said in March that they would end a 22-year-old joint venture to sell vaccines in Europe, arguing they would do better by managing their product portfolios independently.
Source text for Eikon: Further company coverage: